A Fucoxanthinol Induces Apoptosis in a Pancreatic Intraepithelial Neoplasia Cell

Cancer Genomics Proteomics. 2021 Mar-Apr;18(2):133-146. doi: 10.21873/cgp.20248.

Abstract

Background/aim: Fucoxanthinol (FxOH), a predominant metabolite from fucoxanthin (Fx), can exert potential anti-cancer effects in various cancers. However, limited data are available on the effect of FxOH or Fx on pancreatic cancer. The present study investigated the effect of FxOH on a cell line derived from pancreatic cancer tissue developed in Ptf1aCre/+; LSL-k-rasG12D/+ mice.

Materials and methods: Using flow-cytometric, microarrays, and western blotting analyses, alterations in FxOH-induced apoptosis-related gene expression and protein levels were evaluated in a mice pancreatic cancer cell line, KMPC44.

Results: FxOH significantly arrested the cells at S phase along with suppression of many gene sets, such as cytokine- cytokine receptor interaction and cell adhesion molecule CAMS. Moreover, attenuated protein levels for cytokine receptors, adhesion, phosphatidylinositol-3 kinase/protein kinase B, and mitogen-activated protein kinase were observed.

Conclusion: FxOH may prevent pancreatic cancer development in a murine cancer model.

Keywords: Apoptosis; NCAM2; carotenoid; fucoxanthinol; mouse pancreatic cancer.

Publication types

  • Review

MeSH terms

  • Animals
  • Apoptosis
  • Carcinoma in Situ / drug therapy*
  • Disease Models, Animal
  • Female
  • Humans
  • Mice
  • Pancreatic Neoplasms / drug therapy*
  • beta Carotene / analogs & derivatives
  • beta Carotene / pharmacology

Substances

  • beta Carotene
  • fucoxanthinol